Seek Less. Know More.
VivoSeq is biopharma market intelligence based on public data sources.
Leaders
Most Active Sponsors Ranked by the total number of clinical trials each pharma/biotech company sponsors.
Pharmaceutical and biotech companies sponsoring the most clinical trials.
Trending
Pipeline Momentum Diseases with the most momentum, scored by recent new trial starts (last 6 months, weighted most heavily), number of sponsoring companies, and total trial volume.
Disease areas with the most new clinical trials initiated in the past 6 months — where industry is currently pouring resources.
Breast Cancer
Oncology
149
new trialspast 6 mo
968
sponsorsactive
2,146
programsin pipeline
COVID-19
Infectious Disease
8
new trialspast 6 mo
1,047
sponsorsactive
1,444
programsin pipeline
Lymphoma
Oncology
46
new trialspast 6 mo
679
sponsorsactive
1,418
programsin pipeline
Explore
Therapeutic Areas Featured areas are ranked by the total number of pipeline programs across all their diseases. 'Most active diseases' within each are ranked the same way.
Browse the biopharma landscape by clinical focus. Featured areas are those with the most active development.
Oncology
5500 diseases · 30K programs
Most active diseases
Top sponsors
Neurology
688 diseases · 5,116 programs
Most active diseases
Top sponsors
Cardiovascular
806 diseases · 6,321 programs
Most active diseases
Top sponsors
All Areas
Stay ahead of the pipeline
Weekly intelligence brief delivered to your inbox